Top segments and regional performance

Last year, the company generated ‪33.68 M‬ EUR, the most of which — ‪33.68 M‬ EUR — came from its top-performing segment, Zinc Finger Epigenetic Regulators, compared to ‪55.83 M‬ EUR the previous year. The greatest contribution came from United States, which accounted for ‪33.68 M‬ EUR last year, with ‪55.83 M‬ EUR the year before.